ELI LILLY & Co is 436.0x more valuable than Kailera Therapeutics, Inc. by market capitalization ($1.067 T vs $2.45 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | KLRA | LLY |
|---|---|---|
| Market cap | $2.45 B | $1.067 T |
| US-listed rank | #1976 | #11 |
| Revenue (latest FY) | - | $65.18B |
| Net income (latest FY) | - | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 51.7 |
| SEC filings | 52 | 989 |
ELI LILLY & Co is 436.0x more valuable than Kailera Therapeutics, Inc. by market capitalization ($1.067 T vs $2.45 B).
Full pages: Kailera Therapeutics, Inc. and ELI LILLY & Co, or browse the full rankings.